TC
RPTP

TFS Capital’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

TFS Capital’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-135,382
Closed -$727K – 1233
2016
Q2 		$727K Sell
135,382
-324,164
-71% -$1.66M 0.13% 259
2016
Q1 		$2.11M Sell
459,546
-18,338
-4% -$73.7K 0.3% 48
2015
Q4 		$2.48M Buy
+477,884
New +$2.77M 0.27% 119
2015
Q3 		– Sell
-35,300
Closed -$557K – 1229
2015
Q2 		$557K Buy
+35,300
New +$429K 0.05% 489

Other funds holding RPTP

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

TFS Capital's RPTP Position: Q3 2016 in Review

TFS Capital sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 135,382 shares — an estimated $727K sold.

TFS Capital first reported a position in RPTP in Q2 2015 and held it in 4 quarters. The position peaked at $2.48M in Q4 2015. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • TFS Capital reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • TFS Capital sold 135,382 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $727K.
  • TFS Capital first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2015 and held it in 4 quarters.
  • TFS Capital's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.48M in Q4 2015.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on TFS Capital's 13F filing for Q3 2016, filed 10 Nov 2016.